Predictors of the observed high prevalence of loss to follow-up in ART-experienced adult PLHIV: A retrospective longitudinal cohort study in the Tanga Region, Tanzania

Author:

Mushy Stella Emmanuel1,Mtisi Expeditho1,Mboggo Eric2,Mkawe Simon2,Yahya-Malima Khadija I.1,Ndega John2,Ngalesoni Frida2,Muya Aisa2

Affiliation:

1. Muhimbili University of Health and Allied Sciences

2. Amref Health Africa

Abstract

Abstract Background: Antiretroviral therapy (ART) programs have expanded rapidly, and they are now accessible free of charge, yet "loss to follow-up, LTFU" is still a national public health issue. LTFU may result in treatment failure, hospitalization, increased risk of opportunistic infections and drug-resistant strains, and shortening the quality of life. This study described the rates and predictors of LTFU among adult PLHIV on ART in the Tanga region, Tanzania. Methods: A retrospective longitudinal cohort study was conducted between October 2018 and December 2020 in Tanga's care and treatment health services facilities. The participants were HIV adult PLHIV aged 15 years and above on ART and attended the clinic at least once after ART initiation. LTFU was defined as not taking ART refills for three months or beyond from the last attendance of a refill and not yet classified as dead or transferred out. Cox proportional hazard regression models were employed to identify risk factors for LTFU. P values were two-sided, and we considered a p<0.05 statistically significant. Results: 57173 adult PLHIV were on ART, where 10394 (68.78%) were females and 4717 (31.22%) were males. After two years of follow-up, 15111 (26.43%) were LTFU. Factors independently associated with LTFU involved age between 15-19 years (HR:1.85, 95% CI 1.66 – 2.07), male sex (HR:2.00 95% CI 1.51 – 2.62), divorce (HR:1.35, 95% CI 1.24 – 1.48), second-line drug type (HR:1.13, 95% CI 1.09 – 1.18), poor drug adherence (HR:1.50, 95% CI 1.23 – 1.75), unsuppressed viral load (HR: 2.15, 95% CI 2.02 – 2.29), not on DTG-related drug (HR: 7.51, 95% CI 5.88 – 10.79), advanced HIV disease WHO stage III & IV (HR: 2.51, 95% CI 2.32 – 2.72). In contrast to cohabiting, ART duration <1 year, and being pregnant showed a reduced likelihood of LTFU Conclusion: A high prevalence of LTFU was observed in this study. Young age, not using DGT drugs, WHO clinical stage IV, poor drug adherence, male sex, unsuppressed viral load, divorcee, and second-line regime were independently associated with LTFU. To reduce LTFU, evidence-based interventions targeting the identified risk factors should be employed.

Publisher

Research Square Platform LLC

Reference39 articles.

1. UNAIDS. Global HIV. & AIDS Statistics – 2022 fact sheet. 2022; https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.

2. UNAIDS: Global HIV & AIDS statistics — 2019 fact sheet. 2019. https://www.unaids.org/en/resources/fact-sheet.

3. World Health Organization. Global Fund, US Centers for Disease Control and Prevention. HIV drug resistance report 2017. Geneva: World Health Organization: 2017. P.82. https://apps.who.int/iris/bitstream/handle/10665/255896/9789241512831-eng.pdf.

4. Matee M. Pediatric HIV care and treatment services in Tanzania: implications for survival;Somi G;BMC Health Serv Res,2017

5. CLINICAL outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study;Siril HN;AIDS Res Ther,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3